Quanta Therapeutics

About:

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates using allosteric modulation to target driver oncogenes.

Website: https://www.quantatx.com

Top Investors: AbbVie, Sofinnova Investments, Biotechnology Value Fund, Avidity Partners, Longitude Capital

Description:

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes. It develops allosteric modulation to directly restore conformational control of active RAS signaling at the cell membrane to inhibit the full scope of RAS-driven cancer types.

Total Funding Amount:

$141M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2018-01-01

Founders:

Cameron Pitt, Joshua Salafsky

Number of Employees:

11-50

Last Funding Date:

2023-05-22

IPO Status:

Private

Industries:

© 2025 bioDAO.ai